PERSEPT3: A Phase 3 Clinical Trial to Evaluate the Hemostatic Efficacy of Eptacog Beta (Recombinant Human FVIIa) in Perioperative Care in Subjects with Hemophilia Α or B with Inhibitors

Autor: Escobar, Miguel A. *, Quon, Doris, Leissinger, Cindy A., Luck, James V, Jr. *, Al-Sabbagh, Ahmad *, Bonzo, Daniel *, Mitchell, Ian S *, Alexander, W Allan *, Hermans, Cedric
Zdroj: In Blood 5 November 2020 136 Supplement 1:34-36
Databáze: ScienceDirect